Shan Wu
Corporate Officer/Principal chez VIRIDIAN THERAPEUTICS, INC.
Profil
Shan Wu is currently the Chief Business Officer at Viridian Therapeutics, Inc. Prior to this role, she served as the Vice President & Head of Business Development at Magenta Therapeutics, Inc. from 2021 to 2023.
Dr. Wu completed her undergraduate degree at the University of Virginia and holds a doctorate from the Massachusetts Institute of Technology.
Postes actifs de Shan Wu
| Sociétés | Poste | Début |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30/10/2023 |
Anciens postes connus de Shan Wu
| Sociétés | Poste | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 01/09/2023 |
Formation de Shan Wu
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
